Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Groups Defend Supplement Safety After Study Shows Higher Mortality Risk

This article was originally published in The Tan Sheet

Executive Summary

Supplement industry trade groups argue a study that questions the long-term safety of supplements makes unwarranted recommendations.

You may also be interested in...



NBTY Pegs Sports Nutrition To Help Offset Private Label Slump

NBTY prioritizes development of sports nutrition products and wants to broaden the category as it increases its focus on branded sales due to competitive pressure in the private label space.

NBTY Pegs Sports Nutrition To Help Offset Private Label Slump

NBTY prioritizes development of sports nutrition products and wants to broaden the category as it increases its focus on branded sales due to competitive pressure in the private label space.

Study Linking Supplements, Mortality Sparks Questions On Safety, Oversight

A study linking higher mortality with common dietary supplements triggers criticism about the products’ safety and how they are regulated.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel